Article
Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
International journal of cancer - 1 Nov 2001
Nies A T, König J, Pfannschmidt M, Klar E, Hofmann W J, Keppler D
Abstract excerpt
Treatment of hepatocellular carcinoma (HCC) by chemotherapy is often impeded by the intrinsic multidrug resistance (MDR) of this frequent primary cancer of the liver. The MDR phenotype can be caused by ATP-dependent export of chemotherapeutic drugs across the plasma membrane being mediated by transporters of the MDR P-glycoprotein family or of the multidrug resistance protein (MRP) family. To elucidate the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
